Indegene Limited has announced its financial results for the second quarter of fiscal year 2026, reporting $2 million in revenue for the period ending September 30, 2025. The announcement was made during a conference call on October 31, 2025, led by key executives including Chairman and CEO Manish Gupta and CFO Suhas Prabhu. The company has noted a busy few months impacted by external factors, particularly U.S. policy changes affecting the life sciences industry, including most favored nation (MFN) pricing and new tariffs on pharmaceutical imports. These developments are seen as largely positive for the industry, as many companies have adapted by investing in U.S. manufacturing to mitigate tariff impacts.
The MFN pricing agreement announced on September 30 is designed to provide state Medicaid programs access to discounted drug prices from Pfizer, which could influence pricing strategies across the industry. While there are concerns regarding potential price cuts, the overall sentiment is that the agreement will not significantly disrupt the market. Analysts report that the top 30 life sciences companies regained approximately $440 billion in value following these announcements, indicating a market recovery. Moreover, the introduction of tariffs on branded drugs is expected to prompt pharmaceutical companies to bolster domestic manufacturing, thereby cushioning the impact of increased costs.
Indegene's business model remains robust, with a focus on local market expertise rather than labor cost arbitrage, which minimizes the impact of H1B visa changes on its operations. Currently employing around 550 people in the U.S., only a small percentage are on H1B visas. The company has reported a market-leading revenue-per-employee metric, underscoring its efficiency and expertise in navigating complex global healthcare landscapes. As the industry adapts to regulatory changes, Indegene is also investing in digital solutions and artificial intelligence to enhance efficiency and effectiveness in medical and sales marketing processes, aligning with industry trends towards digital adoption.